HKU Scholars Hub: Search

Search

Results 1-25 of 181 (Search time: 0.007 seconds).

previous
1
2
3
4
...
8
next

	Title	Author(s)	Issue Date
	Cervical Cancer - (1) Overview: Epidemiology, Prevention, Screening, Diagnosis (2) Treatment Proceeding/Conference:Joint Meeting of International Cancer Imaging Society & Hong Kong College of Radiologists	Ngan, HYS	2015
	Functional characterization of MAP30 protein from bitter melon (Momordica charantia) in combating ovarian cancer oncogenesis and chemoresistance Proceeding/Conference:International Symposium on AMP-activated Protein Kinase, AMPK 2016	Yung, MH Ngan, HYS Hardie, DG Chan, DW	2016
	How imaging help a gynaecological oncologist Proceeding/Conference:Joint Scientific Meeting of The Royal College of Radiologists & Hong Kong College of Radiologists	Ngan, HYS	2013
	Identification of MAP30 as a natural AMPK activator in targeting the tumorigenicity and chemoresistance of ovarian cancer cells Proceeding/Conference:CSHAsia 2016 Conference on Cancer & Metabolism	Yung, MH Ngan, HYS Chan, DW	2016
	Differential roles of estrogen receptor subtypes and variants in ovarian cancer: implications for personalized hormonal treatment	Ngan, HYS	2014
	miR-135a induced formation of cancer-initialing cell subpopulation in cervical cancer Proceeding/Conference:EMBO 2014 Conference Series: Stem Cells in Cancer & Regenerative Medicine	Pang, TKR Leung, ON Ngan, HYS Yeung, WSB	2014
	Differential expression of estrogen receptor subtypes and variants in ovarian cancer: implications for personalized hormonal treatment Proceeding/Conference:International Workshop on Women's Reproductive Health Research	Chan, KKL Siu, KY Jiang, Y Wang, Y Leung, THY Liu, S Cheung, ANY Ngan, HYS	2014
	Bitter Melon Extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth Proceeding/Conference:Research Postgraduate Symposium, RPS 2012	Yung, MH Chan, DW Ngan, HYS	2012
	SUVmax distinguishes the aggressive from the indolent subtypes of uterine sarcoma	Lee, EYP Khong, PL Tse, KY Chu, MY Chan, KKL Ngan, HYS	2013
	The upregulation of miR-141 confers anoikis resistance through targeting KLF12 in ovarian cancer cells Proceeding/Conference:9th Annual Conference on microRNA: Targets & Tools for Therapeutic Development	Mak, SL Chan, DW Ngan, HYS	2013
	TAp73a enhances the cellular chemosensitivity to cisplatin in ovarian cancer cells Proceeding/Conference:HKICC / RCC 2009	Zhang, P Liu, S Wei, N Leung, THY Ngan, HYS	2009
	Fertility sparing operations in gynaecological oncology Proceeding/Conference:Hong Kong College of Obstetricians and Gynaecologists (HKCOG) Postgraduate Seminar	Ngan, HYS	2012
	Promoter methylation of Delta-TA isoform of p73 regulating the corresponding transcript expression level in gynecological cancers Proceeding/Conference:CSHL Symposium on Molecular Approaches to Controlling Cancer	Chan, YK Liu, S Leung, CY Cheung, ANY Khoo, US Leung, TW Ngan, HYS	2005
	Profiling of differentially expressed genes in persistent gestational trophoblastic disease by complementary DNA expression array Proceeding/Conference:Proceedings of the 5th International Symposium on the Impact of Cancer Biotechnology on Predictive Oncology & Therapy	Fong, PY Tsao, GSW Ngan, HYS Chiu, PM Cheung, ANY	2000
	Has-miR-141/KLF12/Survivin is a crtical pathway required for enhancing anoikis resistance of advanced ovarian cancer Proceeding/Conference:CSHAsia 2015 Conference on Targeting Cell Death Mechanisms for the Treatment of Human Diseases	Chan, DW Mak, SL Ngan, HYS	2015
	BCL2A1 plays a biphasic role in ovarian cancer progression: promoting cell survival and inhibiting cell proliferation Proceeding/Conference:CSHAsia 2016 Conference on Cancer & Metabolism	Liang, R Yung, MH Ngan, HYS Chan, DW	2016
	Targeting AMPK as a valid therapeutic intervention in ovarian cancer Proceeding/Conference:International Workshop on Women's Reproductive Health Research	Chan, DW Ngan, HYS	2014
	Has-miR-141 plays a crucial role in ovarian cancer metastatic progression Proceeding/Conference:HKU O & G 90th Anniversary Celebration Symposium	Chan, DW MAK, SL Ngan, HYS	2015
	BCL2A1 plays a biphasic role in ovarian cancer progression Proceeding/Conference:Research Postgraduate Symposium, RPS 2014	Liang, R Ngan, HYS Chan, DW	2014
	Role of FOXM1 in ovarian carcinogenesis Proceeding/Conference:Clinical Cancer Research	Zhao, F Siu, KY Wong, GW Wong, ESY Jiang, LL Tam, KF Ngan, HYS Le, XF Lam, EWF Cheung, ANY	2013
	The significance of lipid metabolism in peritoneal metastases of ovarian cancer Proceeding/Conference:CSHAsia 2016 Conference on Cancer & Metabolism	Chan, DW Mak, SL Ngan, HYS	2016
	Identification of cisplatin-resistance related genes in Ovarian clear cell carcinoma using 3D cell culture model Proceeding/Conference:Research Postgraduate Symposium, RPS 2014	Liu, J Ngan, HYS Chan, DW	2014
	Role of Has-miR-141 as a therapeutic target and predictive biomarker for ovarian cancer Proceeding/Conference:CSHAsia 2015 Conference on Precision Cancer Biology & Medicine	Chan, D Mak, SL Ngan, HYS	2015
	Targeting TAK1/NF-κB signalling axis abrogates omental metastasis of ovarian cancer Proceeding/Conference:CSHAsia 2013 Conference on Cell Signaling in Metabolism, Inflammation & Cancer	Chan, DW Cai, C Ngan, HYS	2013
	MAP30 protein of momordica charantia functions as a natural AMPK activator in combating tumorigenic and chemoresistant capacities of ovarian cancer Proceeding/Conference:Croucher ASI 2013 on Tumour Microenvironment - Cancer Cell Metabolism	Chan, DW Yung, MH Ngan, HYS	2013